Skip to main content

Table 2 Associations of Bisphenols with total CVD risk in US adults 2013–2016

From: The bisphenol F and bisphenol S and cardiovascular disease: results from NHANES 2013–2016

Variables

Model 1

Model 2

Model 3

OR (95% CI)

P

OR (95% CI)

P

OR (95% CI)

P

Bisphenol S

T1

1.00

1.00

1.00

1.00

1.00

1.00

T2

0.89 (0.40, 1.99)

0.767

0.97 (0.42, 2.24)

0.941

0.98 (0.44, 2.20)

0.956

T3

1.37( 0.80, 2.35)

0.240

1.96 (1.12, 3.40)

0.019*

1.99 (1.16, 3.40)

0.014**

P for trend

 

0.236

 

0.014*

 

0.011*

Bisphenol F

T1

1.00

1.00

1.00

1.00

1.00

1.00

T2

1.57 (0.88, 2.78)

0.120

1.72 (0.93, 3.20)

0.083

1.69 (0.88, 3.27)

0.111

T3

1.54 (0.82, 2.89)

0.174

1.72 (0.82, 3.61)

0.142

2.02 (0.86, 4.72)

0.101

P for trend

 

0.197

 

0.173

 

0.121

Bisphenol A

 T1

1.00

1.00

1.00

1.00

1.00

1.00

 T2

0.51 (0.27, 0.96)

0.039

0.63 (0.30, 1.32)

0.095

0.66 (0.33, 1.30)

0.218

 T3

0.69 (0.40, 1.20)

0.180

0.63(0.27, 1.46)

0.272

0.65 (0.29, 1.45)

0.283

 P for trend

 

0.185

 

0.264

 

0.273

  1. Model 1: unadjusted model
  2. Model 2: adjusted for urine creatinine, sex, age, race, education level, PIR, physical activity, alcohol drinking status, smoking status, BMI, blood pressure, and diabetes
  3. Model 3: adjusted for urine creatinine, sex, age, race, education level, PIR physical activity, alcohol drinking status, smoking status, BMI, blood pressure, diabetes, LDL-C, and energy intake; * p< 0.05;  ** p< 0.01; *** p< 0.001. The bold values indicate statistically significant differences